HK60894A - Pharmaceutical compositions containing furan derivatives - Google Patents

Pharmaceutical compositions containing furan derivatives

Info

Publication number
HK60894A
HK60894A HK60894A HK60894A HK60894A HK 60894 A HK60894 A HK 60894A HK 60894 A HK60894 A HK 60894A HK 60894 A HK60894 A HK 60894A HK 60894 A HK60894 A HK 60894A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
compositions containing
furan derivatives
containing furan
salt
Prior art date
Application number
HK60894A
Other languages
English (en)
Inventor
Norman Richard Smith
Colin Roy Heppenstall
Stephen John Douglas
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK60894A publication Critical patent/HK60894A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
HK60894A 1990-09-11 1994-06-23 Pharmaceutical compositions containing furan derivatives HK60894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909019875A GB9019875D0 (en) 1990-09-11 1990-09-11 Pharmaceutical compositions
NO920408A NO179694C (no) 1990-09-11 1992-01-30 Farmasöytiske preparater inneholdende ranitidinderivater
PCT/EP1992/000498 WO1993017679A1 (en) 1990-09-11 1992-03-05 Compositions containing ranitidine/bismuth carboxylates salts

Publications (1)

Publication Number Publication Date
HK60894A true HK60894A (en) 1994-07-08

Family

ID=47884627

Family Applications (1)

Application Number Title Priority Date Filing Date
HK60894A HK60894A (en) 1990-09-11 1994-06-23 Pharmaceutical compositions containing furan derivatives

Country Status (33)

Country Link
US (1) US5456925A (no)
EP (1) EP0558779B1 (no)
JP (1) JPH0692849A (no)
KR (1) KR100196308B1 (no)
AT (2) AT405134B (no)
AU (2) AU640816B2 (no)
BE (1) BE1005115A5 (no)
BG (1) BG61931B1 (no)
CA (1) CA2050970C (no)
CH (1) CH683068A5 (no)
CY (1) CY1988A (no)
DE (2) DE4130061A1 (no)
DK (1) DK159191A (no)
ES (1) ES2072647T3 (no)
FI (1) FI944047A (no)
FR (1) FR2666508B1 (no)
GB (2) GB9019875D0 (no)
HK (1) HK60894A (no)
HU (1) HU211846A9 (no)
IE (1) IE65049B1 (no)
IL (1) IL99428A (no)
IT (1) IT1249696B (no)
MX (1) MX9101009A (no)
NL (1) NL194907C (no)
NO (1) NO179694C (no)
NZ (1) NZ239731A (no)
OA (1) OA10093A (no)
RO (1) RO112084B1 (no)
RU (1) RU2108097C1 (no)
SE (1) SE509694C2 (no)
SK (1) SK279591B6 (no)
WO (1) WO1993017679A1 (no)
ZA (1) ZA917176B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As, Oslo Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
WO2000010562A1 (fr) * 1998-08-18 2000-03-02 Leonidov Nikolai B Forme physiquement stable et amorphe aux rayons x de ranitidine d'hydrochlorure ayant une action anti-ulcere accrue, et procede de production
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
MX337488B (es) * 2008-07-21 2016-03-08 Si Group Inc Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608257A (en) * 1984-01-03 1986-08-26 Board Of Regents For Oklahoma State University Composition and method for treating heat stress
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
CH679582A5 (no) * 1988-07-18 1992-03-13 Glaxo Group Ltd
DE3865201D1 (de) * 1988-10-08 1991-10-31 Pfleger R Chem Fab Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0692849A (ja) 1994-04-05
DE69202696D1 (de) 1995-06-29
AU640816B2 (en) 1993-09-02
WO1993017679A1 (en) 1993-09-16
NO920408L (no) 1993-08-02
CY1988A (en) 1997-09-05
BE1005115A5 (fr) 1993-04-27
DK159191A (da) 1992-03-12
MX9101009A (es) 1992-05-04
CA2050970A1 (en) 1992-03-12
GB9019875D0 (en) 1990-10-24
NL194907C (nl) 2003-07-04
GB9119284D0 (en) 1991-10-23
ITRM910673A0 (it) 1991-09-10
NO179694B (no) 1996-08-26
EP0558779A1 (en) 1993-09-08
KR100196308B1 (ko) 1999-06-15
IE65049B1 (en) 1995-10-04
SK279591B6 (sk) 1999-01-11
DE4130061A1 (de) 1992-03-12
AT405134B (de) 1999-05-25
RU2108097C1 (ru) 1998-04-10
NO179694C (no) 1996-12-04
FI944047A0 (fi) 1994-09-02
ATE122883T1 (de) 1995-06-15
OA10093A (en) 1996-12-18
NL194907B (nl) 2003-03-03
SE9102604L (sv) 1992-03-12
ZA917176B (en) 1992-06-24
GB2248185B (en) 1994-02-02
CH683068A5 (fr) 1994-01-14
SK106094A3 (en) 1995-02-08
HU211846A9 (en) 1995-12-28
AU8375791A (en) 1992-03-19
NL9101533A (nl) 1992-04-01
NO920408D0 (no) 1992-01-30
ES2072647T3 (es) 1995-07-16
FI944047A (fi) 1994-09-02
IT1249696B (it) 1995-03-09
RO112084B1 (ro) 1997-05-30
GB2248185A (en) 1992-04-01
US5456925A (en) 1995-10-10
EP0558779B1 (en) 1995-05-24
KR920005984A (ko) 1992-04-27
CA2050970C (en) 2002-11-19
BG61931B1 (bg) 1998-10-30
AU1334792A (en) 1993-10-05
ATA180191A (de) 1998-10-15
IE913191A1 (en) 1992-04-22
NZ239731A (en) 1993-10-26
SE509694C2 (sv) 1999-02-22
IL99428A0 (en) 1992-08-18
FR2666508A1 (fr) 1992-03-13
DK159191D0 (da) 1991-09-10
BG99021A (bg) 1995-06-30
IL99428A (en) 1996-06-18
SE9102604D0 (sv) 1991-09-10
ITRM910673A1 (it) 1993-03-10
FR2666508B1 (fr) 1994-02-18

Similar Documents

Publication Publication Date Title
TW427914B (en) Mycophenolate mofetil high dose oral suspensions
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
GB2248185B (en) Pharmaceutical compositions containing furan derivatives
MX18786A (es) Complejos macrociclicos de acido aminofonico, su preparacion, formulaciones y empleo.
SE8702941D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
NO893142D0 (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
IE873367L (en) Ranitidine-ethanol formulation
AU4704279A (en) Pharmaceutical formulations of prostacyclin
GB2021581A (en) Stabilisation of PGl2 derivatives
AU7680187A (en) Epoxy oligosaccharides
JPS5331665A (en) Optical active chlorophenylalanine. acylphenylglycine salt and its preparation
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
JPS5283517A (en) Novel derivatives of antibiotics xk-62-2
JPS53105470A (en) Novel sulfone and their preparation
GB2162746A (en) Antiacidotic medicinal agent

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060910